References

Robenacoxib shows efficacy for the treatment of chronic degenerative joint disease-associated pain in cats: a randomized and blinded pilot clinical trial

10.1038/s41598-021-87023-2 · 2021 · External reference

Augmented pain behavioural responses to intra-articular injection of nerve growth factor in two animal models of osteoarthritis

10.1136/annrheumdis-2013-203416 · 2014 · External reference

Biologics in the treatment of chronic pain: a new era of therapy?

10.1002/cpt.20 · 2015 · External reference

Assessment of quality of life and chronic pain in dogs

10.1016/j.tvjl.2018.07.010 · 2018 · External reference

Feline osteoarthritis: a prospective study of 28 cases

10.1111/j.1748-5827.2006.00143.x · 2006 · External reference

A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis

10.1016/j.vaa.2021.08.001 · 2021 · External reference

Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats

10.1136/vr.104590 · 2019 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Osteoarthritis in cats: A retrospective radiological study

10.1111/j.1748-5827.2005.tb00340.x · 2005 · External reference

Detection of clinically relevant pain relief in cats with degenerative joint disease associated pain

10.1111/jvim.12312 · 2014 · External reference

Criterion validation testing of clinical metrology instruments for measuring degenerative joint disease associated mobility impairment in cats

10.1371/journal.pone.0131839 · 2015 · External reference

2022 aaha pain management guidelines for dogs and cats

10.5326/jaaha-ms-7292 · 2022 · External reference

Efficacy and safety of an anti-nerve growth factor antibody (frunevetmab) for the treatment of degenerative joint disease-associated chronic pain in cats: a multisite pilot field study

10.3389/fvets.2021.610028 · 2021 · External reference

Frunevetmab, a felinized anti-nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats

10.1111/jvim.16291 · 2021 · External reference

A feline-specific anti-nerve growth factor antibody improves mobility in cats with degenerative joint disease-associated pain: a pilot proof of concept study

10.1111/jvim.13972 · 2016 · External reference

Evaluation of tramadol for treatment of osteoarthritis in geriatric cats

10.2460/javma.252.5.565 · 2018 · External reference

Assessment of the effects of gabapentin on activity levels and owner-perceived mobility impairment and quality of life in osteoarthritic geriatric cats

10.2460/javma.253.5.579 · 2018 · External reference

Broadening the veterinary consultation: dog owners want to talk about more than physical health

10.3390/ani13030392 · 2023 · External reference

A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis

10.3389/fvets.2025.1502218 · 2025 · External reference

Nerve growth factor concentrations in the synovial fluid from healthy dogs and dogs with secondary osteoarthritis

10.3415/vcot-10-04-0051 · 2011 · External reference

Nerve growth factor in the equine joint

10.1016/j.tvjl.2020.105579 · 2021 · External reference

Clinical safety of robenacoxib in cats with chronic musculoskeletal disease

10.1111/jvim.16148 · 2021 · External reference

Evaluation of client-specific outcome measures and activity monitoring to measure pain relief in cats with osteoarthritis

10.1111/j.1939-1676.2007.tb02983.x · 2007 · External reference

Cross-sectional study of the prevalence of radiographic degenerative joint disease in domesticated cats

10.1111/j.1532-950x.2010.00708.x · 2010 · External reference

Measurement of chronic pain in companion animals: discussions from the pain in animals workshop (paw) 2017

10.1016/j.tvjl.2019.07.001 · 2019 · External reference

Prevalence and classification of chronic kidney disease in cats randomly selected from four age groups and in cats recruited for degenerative joint disease studies

10.1177/1098612x13511446 · 2014 · External reference

A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the united states of america evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody

10.1016/j.vaa.2023.06.003 · 2023 · External reference

Analgesic efficacy of an oral transmucosal spray formulation of meloxicam alone or in combination with tramadol in cats with naturally occurring osteoarthritis

10.1111/vaa.12360 · 2016 · External reference

Analgesic efficacy of tramadol in cats with naturally occurring osteoarthritis

10.1371/journal.pone.0175565 · 2017 · External reference

2022 wsava guidelines for the recognition, assessment and treatment of pain

10.1111/jsap.13566 · 2023 · External reference

Chronic pain in cats: recent advances in clinical assessment

10.1177/1098612x19856179 · 2019 · External reference

Neuropilin-1 inhibition suppresses nerve growth factor signaling and nociception in pain models

10.1172/jci183873 · 2024 · External reference

Safety and toxicokinetic profiles associated with daily oral administration of grapiprant, a selective antagonist of the prostaglandin e2 ep4 receptor, to cats

10.2460/ajvr.77.7.688 · 2016 · External reference

Measuring the effect of the anti-nerve growth factor antibodies bedinvetmab and frunevetmab on quality of life in dogs and cats with osteoarthritis using a validated health-related quality of life outcome measure: an observational real-world study

10.3389/fvets.2024.1395360 · 2024 · External reference

Owner evaluation of quality of life and mobility in osteoarthritic cats treated with amantadine or placebo

10.1177/1098612x20967639 · 2021 · External reference

Difficulties in administration of oral medication formulations to pet cats: an e-survey of cat owners

10.1136/vr.103991 · 2017 · External reference

Cross-sectional study of the prevalence and clinical features of osteoarthritis in 100 cats

10.1016/j.tvjl.2009.12.014 · 2011 · External reference

Acute pain in cats: Recent advances in clinical assessment

10.1177/1098612x18808103 · 2019 · External reference

2024 isfm and aafp consensus guidelines on the long-term use of nsaids in cats

10.1177/1098612x241241951 · 2024 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis

10.1093/rheumatology/keq188 · 2010 · External reference

Immunohistochemical study of ngf and its receptors in the synovial membrane of the ankle joint of adjuvant-induced arthritic rats

10.1007/s004180000222 · 2000 · External reference